Results 161 to 170 of about 64,761 (239)

Invasive Pulmonary Aspergillosis: Not Everything that Glitters is Cancer. [PDF]

Open Respir Arch
Caballero LM, Calvo GGV, Romero JJG.
europepmc   +1 more source

Five-year competing-risk analysis of infectious and noninfectious complications after lung transplantation: Real-world evidence from a multicenter EHR-based cohort. [PDF]

JHLT Open
Contreras GA, Golovko G.
europepmc   +1 more source

Beyond the Norm: Atypical Manifestations of Aspergillosis. [PDF]

Respirol Case Rep
Zahiri L, Fallahi MJ, Hosseinzadeh M, Alemzadeh N, Ghanbarinasab Z, Razmjooei F.   +5 more
europepmc   +1 more source

An Evolving Challenge: Fungal Infections in the Contemporary ICU. [PDF]

J Fungi (Basel)
Soubani AO.
europepmc   +1 more source

Therapeutic drug monitoring-guided optimization of isavuconazole dose for ICU patients with refractory pulmonary aspergillosis: case report. [PDF]

Front Med (Lausanne)
Yang M, He X, Lu Q, Bian X, Fang J, Ding Y.   +5 more
europepmc   +1 more source

One-year clinical, radiological, and functional outcomes following antifungal therapy for aspergillus infection in lung transplant recipients. [PDF]

JHLT Open
Lelièvre A, Murris M, Dupuis M, Mourlanette J, Le Borgne A, Collot S, Marion O, Kamar N, Guibert N, Villeneuve T.   +9 more
europepmc   +1 more source

Aspergillosis Update

Medicine, 2000
openaire   +2 more sources

Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis. [PDF]

Cureus
Akagawa Y, Egawa N, Shimizu T, Shinkai Y, Ono S, Koga S, Ishikawa K.   +6 more
europepmc   +1 more source